Molecular Templates, Inc. Public Market Comparables
Find the most relevant public market comparables for Molecular Templates, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
A clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells using a proprietary drug platform technology, Engineered Toxin Bodies (ETBs), to create novel therapies with potent and differentiated mechanisms of action for cancer and various disease indications. The company is no longer operating.
Business Model
Clinical-stage biopharmaceutical company developing and commercializing cancer therapies.
Target Customers
Patients with cancer.
Specific Focus
Antibody-drug conjugates (ADCs) and engineered toxin bodies (ETBs) for cancer treatment.
Location
Austin, Texas
CEO
Eric Poma
Industry
Life sciences
Sub Sector
Biopharmaceuticals
3yr Revenue Growth
204%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Molecular Templates, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Molecular Templates, Inc.? Our platform provides detailed analysis of Molecular Templates, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Molecular Templates, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Molecular Templates, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Molecular Templates, Inc. operates in the specialized Biopharmaceuticals sub-sector. Understanding how Molecular Templates, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Lineage Cell Therapeutics, Inc.
Biotechnology • Life sciences
A clinical-stage biotechnology company developing allogeneic, or “off the shelf”, cell therapies for serious neurological and ophthalmic conditions. The company develops and manufactures specialized human cells to replace or support dysfunctional or absent cells due to degenerative disease or traumatic injury.
Sutro Biopharma Inc.
Biotechnology • Life sciences
Sutro Biopharma, Inc. is a clinical-stage oncology company focused on discovering and developing precisely designed cancer therapeutics using its proprietary cell-free protein synthesis platform, XpressCF+. The company develops next-generation protein therapeutics for cancer and autoimmune disorders, focusing on antibody-drug conjugates (ADCs), cytokine-based immuno-oncology therapies, and bispecific antibodies.
Mersana Therapeutics, Inc.
Pharmaceuticals & Biotechnology • Life sciences
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Molecular Templates, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free